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A Mouse Cytomegalovirus Glycoprotein
Retains MHC Class I Complexes
in the ERGIC/cis-Golgi Compartments
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Herpesviruses establish lifelong infections despite theSummary
presence of an active immune system. The observation
that presentation of a viral antigen of mouse cytomega-The principle by which mouse cytomegalovirus blocks
lovirus (MCMV), a b-herpesvirus, is tightly controlledantigen presentation in the MHC class I pathway was
during the phases of the replication cascade (Redde-investigated. The responsible gene m152, encoding a
hase et al., 1986; Del Val et al., 1989) led to the findingtype I transmembrane glycoprotein of 40 kDa, is a
that MCMV early genes regulate the expression of MHCmember of a gene family located in the right-hand
class I molecules (Del Val et al., 1992; Campbell et al.,terminal region of the 230 kb virus genome. Expression
1994). The CMV effect on antigen presentation has beenof m152 in murine and human cells arrested the export
confirmed for human CMV (HCMV) (Beersma et al., 1993;of mouse class I complexes from the ER–Golgi inter-
Yamashita et al., 1993; Warren et al., 1994). Herpes sim-mediate compartment/cis-Golgi compartment and in-
plex virus type 1 (HSV-1) was found to code for a proteinhibited lysis by cytotoxic T cells. The plasma mem-
that inhibits antigen presentation (York et al., 1994). Thisbrane transport of human MHC class I molecules was
cytosolic protein interacts with the TAP molecules andnot affected. The deletion of the cytoplasmic tail of
thus prevents peptide translocation (Hill et al., 1995;gp40 did not lift its effect on class I molecule export,
Fru¨h et al., 1995).indicating that this protein differs in its functions from
known immunosubversive viral gene products and We have identified the genomic region of MCMV re-
represents a novel principle by which a herpesvirus sponsible for the inhibition of MHC class I–restricted
shuts off MHC class I function. antigen presentation (Tha¨le et al., 1995). With a method
similar to that used for the isolation of the gene encoding
Introduction the Fc receptor of MCMV (Tha¨le et al., 1994), we have
now isolated the gene causing the MHC class I transport
The T cell–mediated immune response plays a central arrest. Here we report on gene m152 of MCMV, which
role in the defense against intracellular pathogens. T is expressed early after infection and codes for a 37/40
cells that express ab receptors are specialized for rec- kDa glycoprotein. This glycoprotein selectively arrests
ognition of peptides presented by major histocompati- the maturation and plasma membrane transport of
bility complex (MHC)-encoded molecules (Yewdell and newly synthesized murine but not human MHC class I
Bennink, 1992). Proteins that are synthesized during vi- complexes in a post-ER/early Golgi compartment and
ral gene expression are degraded in the cytosol by the thus prevents the presentation of peptide antigens.
proteasome, and peptides are translocated by trans-
porters associated with antigen processing (TAP) the
Resultspeptide assembles with the MHC class I heavy chain
and b2-microglobulin to form a trimeric complex. This
Intracellular Accumulation of MHC Class Imature complex is then transported from the endoplas-
Molecules Induced by the MCMVmic reticulum (ER) through the ER–Golgi intermediate
m152 Genecompartment (ERGIC)/cis-Golgi network, the medial-
During the early phase of MCMV gene expression, viralGolgi, and the trans-Golgi network to the plasma mem-
functions block the Golgi egress of newly synthesizedbrane, where the MHC complex presents the peptide
to CD8 cytotoxic T cells. MHC class I complexes (Del Val et al., 1992). Instead of
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BssHII, SphI, and ClaI, which cut the EcoRI O fragment
only once and within this ORF, confirmed this location.
This ORF was selectively cloned into an expression vec-
tor, and the intracellular accumulation of H-2Kd in its
microinjected cells gave the first indication for the cor-
rect gene identification.
The gene was named m152 (m for murine CMV and
152 for the position number in the genome map) (Ebeling
et al., 1983). The m152 ORF (1137n) predicts a protein
of 378 amino acids. The first ATG is 125n downstream
from the predicted TATA box in a favorable context for
initiation of translation. The polyadenylation consensus
sequence is 163n downstream from the stop codon. No
significant nucleotide sequence homology to any known
gene sequence was found.
The putative amino acid sequence of the m152 ORF
codes for a type I transmembrane glycoprotein with a
calculated mass of 42 kDa (Figure 1, middle). A hy-
drophobic region at the N-terminus represents a poten-
tial signal peptide sequence of 19 amino acid residues; a
second hydrophobic region of 17 amino acids probably
serves as transmembrane segment. The cytoplasmic
tail of 26 amino acids contains a YRLV sequence similar
to the general YXXF motif (Y, tyrosine; X, any amino
acid; F, hydrophobic amino acid) that directs proteins
to endosomes or lysosomes (Guarnier et al., 1993). The
luminal portion of approximately 317 amino acid resi-
dues has three potential N-linked glycosylation sites.
Figure 1. The m152 Gene of MCMV Within the MCMV genome the m152 belongs to a gene
(Top) Top line, HindIII cleavage map of the 230 kb MCMV genome. family of eight members. Most of them cluster around
Second line, position in the HindIII E fragment and direction of
m152. All members of this family code for glycoproteinstranscription of the m152 gene (bold arrow) and a number of related
and are characterized by identical localizations of thegenes (arrows). The location of the EcoRI O fragment is indicated
C and W amino acid residues.by open triangles.Third line, proportional representation of the m152
ORF with signal peptide (SP), glycosylation sites (branched sym-
bols), transmembrane region (TM), and cytoplasmic tail (CT) indi-
cated. Transcription and Expression Kinetics
(Middle) Putative amino acid sequence of the m152 ORF. Shown in of the m152 Gene
bold are the signal peptide, the glycosylation sites, and the trans-
The MCMV effect on antigen presentation starts at earlymembrane region. The peptide sequence used for preparation of a
times in infection (Reddehase et al., 1986) and requiresrabbit antiserum is underlined.
about 30 min of viral early gene transcription and subse-(Bottom) Hydrophilicity blot of the predicted protein.
quent translation (Del Val et al., 1989). To determine
whether the expression kinetics of the m152 mRNA ful-
fils this expectation, total cellular RNA was isolated atbeing rapidly degraded, the molecules are retained in
the infected cell. To locate genes within the MCMV ge- different times after infection and a Northern blot hybrid-
ization was performed. Hybridization with strand-spe-nome that result in intracellular MHC class I molecule
accumulation, we microinjected MCMV DNA fragments cific probes showed two transcripts of 1.4 and 2.6 kb
(Figure 2a). Both transcripts originate from the sameand studied the intracellular distribution of newly syn-
thesized MHC class I Kd molecules by indirect immuno- strand, since there was no hybridization to transcripts
from the opposite strand (data not shown). Consideringfluorescence. This method, combined with theconstruc-
tion of virus mutants, had restricted the coding region the predicted size of m152 mRNA and the size of the
shortest DNA fragment that demonstrated the MHC re-to a 5.9 kb domain located in the right-hand end of the
MCMV genome (Tha¨le et al., 1995). To determine which tention phenotype, the 1.4 kb transcript must represent
the m152 mRNA. Transcription started 2 hr postinfec-restriction enzyme would destroy the gene function, the
internal EcoRI O fragment within the HindIII E fragment tion, reached a maximum 4 hr postinfection, and contin-
ued throughout the MCMV replication cycle of 24 hr.(Figure 1) was cleaved with a number of restriction en-
zymes, and the DNA fragments were injected into cells. An antiserum against the m152 polypeptide was pro-
duced by immunization of rabbits with a synthetic pep-For example, after cleavage of MCMV EcoRI O DNA
with XbaI no effect on the MHC class I distribution was tide (Figure 1, sequence underlined). The peptide anti-
serum reacted with a 40 kDa protein from lysates ofseen, whereas cells injected with SmaI-digested DNA
cells showed an intracellular accumulation of MHC com- MCMV-infected cells (Figure 3a, second lane) in a West-
ern blot analysis. Immunoprecipitation at different timesplexes. Only one of the open reading frames (ORFs)
located in the EcoRI O fragment is cleaved by XbaI of infection showed that gp40 synthesis starts 3–4 hr
postinfection and has a maximum of expression at 5–6but not by SmaI. Cleavage with the restriction enzymes
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Figure 2. Expression of the m152 Gene during the Replication Cycle
of MCMV
(a) m152 RNA transcription kinetics. RNA was isolated from MCMV-
infected and mock-infected fibroblasts at the indicated times. The
Northern blot analysis was conducted using 5 mg of RNA per lane
and employing as probe a 32P-labeled riboprobe that encoded
MCMV m152 (top) and as control a cDNA probe for the murine actin
gene (bottom).
(b) Expression of m152-encoded polypeptides during the replication Figure 3. Biochemical Properties of gp40
cycle of MCMV. Mock-infected and MCMV-infected cells were ra- (a) Expression of the m152 product gp40 by recombinant vaccinia
diolabeled with [35S]methionine for 60 min at the indicated times virus. B12 fibroblasts were mock infected or infected with MCMV,
postinfection. Lysates were immunoprecipitated with rabbit antise- with the MCMV deletion mutant DMS94.5 (Tha¨le et al., 1995), which
rum to the m152 peptide (top) and with rabbit antiserum to the lacks the region encoding m152, or with the m152 vaccinia recombi-
cellular 14-3-3 protein as a control (bottom) and analyzed by reduc- nant. At 12 hr postinfection, cells were lysed and proteins were
ing 10% SDS–polyacrylamide gel electrophoresis (SDS–PAGE). separated by reducing 10% SDS–PAGE and blotted. The binding
of peptide antiserum was visualized using peroxidase-conjugated
second antibody.
(b) gp40 and gp37 represent two different glycosylated forms of the
hr after infection (Figure 2b). Endoglycosidase H (endo m152 gene product. Mock-infected or MCMV-infected B12 cells
H) digestion of the precipitated products indicated the were incubated with tunicamycin, an inhibitor of N-glycosylation.
usage of all three predicted sites for N-linked carbohy- Cells were 35S labeled for 1 hr, and gp40/gp37 was immunoprecipi-
tated with the rabbit anti-gp40 antiserum. The proteins were sepa-drates (data not shown).
rated by 10% SDS–PAGE.
(c) gp40 has a short half-life and acquires endo H resistance. m152-
Vac-infected B12 cells were pulse labeled with [35S]methionine 4 hrExpression of gp40 by a Recombinant
postinfection for 30 min. Immediately after pulse or after 3 hr ofVaccinia Virus
chase, gp40/gp37 was immunoprecipitated with the rabbit anti-gp40
To test the function of gp40, we constructed a recombi- antiserum and subjected to endo H digestion or was mock digested.
nant vaccinia virus containing the MCMV ORF m152 Proteins were analyzed by 10% SDS–PAGE.
(m152-Vac). Proteins synthesized in m152-Vac-infected
cells were compared with proteins synthesized in
MCMV-infected cells by Western blot (Figure 3a). Pro- m152 gene, since it was found also in wild-type vaccinia-
infected cells (see also Figure 8a). Notably, the peptideteins with the apparent molecular mass of 40 and 37
kDa were similarly expressed in cells infected with the antiserum to gp40 did not coprecipitate class I mole-
cules (data not shown). The addition of tunicamycin,m152-Vac as in MCMV-infected cells. These proteins
were absent in cells infected with the MCMV mutant which inhibits de novo synthesis of N-linked oligosac-
charides to MCMV-infected cells, resulted in the appear-DMS94.5 that lacks the region encoding m152 (Tha¨le et
al., 1995). A faster migrating band detected in m152- ance of only one protein band of about 34 kDa (Figure
3b), indicating that gp40 and gp37 represent differentVac-infected cells does not represent a product of the
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glycosylated forms of the m152 gene product. The viral
proteins have a half-life of about 2.5 hr. After 3 hr of
chase, the gp40 molecules acquired endo H resistance
(Figure 3c). The endo H–resistant form of gp40 migrated
at a position between 40 kDa and the 37 kDa forms.
gp40 Blocks Plasma Membrane Expression
of Class I Molecules
To study the effect of gp40 on the fate of newly synthe-
sized class I complexes, L-m152 transfectants were pre-
pared that allowed the inducible expression of the pro-
tein. The location of the MHC class I complex was
monitored by fluorescence-activated cell sorting (FACS)
analysis using a Kk-specific antibody (Figure 4a). In the
absence of gp40 induction, there was no significant ef-
fect upon plasma membrane expression of Kk mole-
cules. After induction of gp40 expression by dexametha-
sone, however, there was a clear reduction of Kk
molecules. Dexamethasone had no effect on Kk mole-
cules in parental cellsand plasmamembrane expression
of CD44 was not influenced after induction of gp40 (Fig-
ure 4a), which is consistent with previous findings in
which the plasma membrane residence of transferrin
receptors was not altered by the MCMV function (Del
Val et al., 1992).
Expression of gp40 Inhibits Antigen Presentation
to Specific Cytotoxic T Lymphocytes
At early times in MCMV replication, the presentation of
the protein pp89 of MCMV by the MHC class I molecule
Ld is inhibited (Del Val et al., 1989). To study antigen
presentation in presence of gp40 as the only MCMV
protein, murine Ld–expressing fibroblasts were infected
with a vaccinia recombinant encoding pp89 (Volkmer et
al., 1987) in presence or absence of m152-Vac. Antigen
Figure 4. m152 Prevents MHC Class I Surface Expression and Anti-presentation was tested with pp89 peptide–specific cy-
gen Presentation to CD8 T Lymphocytestotoxic T lymphocyte (CTL), and target cell lysis was
(a) m152 gene expression reduces the plasma membrane expres-determined by a 51Cr release assay. Cells infected with
sion of newly synthesized MHC class I molecules, but not CD44the pp89-Vac recombinant were lysed, as well as cells
(Pgp-1). Mouse L cells (H-2k) transfected with the m152 gene undercoinfected with pp89-Vac and wild-type Vac (Figure 4b).
the control of a steroid-inducible promoter were either mock treated
After coinfection of cells with pp89-Vac and m152-Vac, or induced with dexamethasone for 24 hr. The plasma membrane
however, antigen presentation was significantly re- expression of the H-2 allele Kk and CD44 was assessed by FACS
duced. A 40-fold higher number of effector cells was analysis. The dotted line indicates the FITC control in the absence
of the primary antibody. To control the influence of dexamethasonerequired to reach a similar degree of specific lysis. Thus,
on MHC class I molecules, parental L cells were also analyzed forexpression of the isolated gp40 protein of MCMV suf-
plasma membrane Kk expression.fices to block antigen presentation.
(b) MCMV m152 blocks antigen presentation in the MHC class I
pathway. BALB/c fibroblasts were infected with pp89-Vac alone or
were coinfected with pp89-Vac and either wild-type Vac or m152-gp40 Retains MHC Class I Molecules
Vac. Controls were mock infected. Presentation of pp89 peptidesin an Endo H–Sensitive State
was tested by H-2 Ld–restricted CTL specific for the nonapeptideThe MCMV effect on MHC class I transport is reflected
of pp89 at the indicated effector to target (E/T) cell ratios in a 4 hr
by the altered glycosylation pattern of newly synthe- 51Cr release assay.
sized molecules (Del Val et al., 1992). Correctly assem-
bled MHC class I complexes mature steadily and enter
the medial Golgi compartment, where they acquire a during the chase period (Figure 5). In m152-Vac- and
MCMV-infected cells, the Kd molecules remained in theglycan structure that is resistant to cleavage by endo
H. Murine fibroblasts were infected with m152-Vac and slightly faster migrating form that is susceptible to endo
H cleavage, typical for ER–cis-Golgi-located glycopro-labeled with [35S]methionine at 4 hr postinfection for 60
min, followed by a 2 hr chase period before immunopre- teins. Endo H–sensitive MHC class Imolecules remained
stable for more than 6 hr (see Figure 7). This result sug-cipitation of Kd molecules was performed. In mock-
infected cells and cells infected with wild-type Vac virus gested that the isolated m152 gene prevents the trans-
port of MHC complexes.the bulk of Kd molecules acquired endo H resistance
MHC Class I Retention by a Viral Gene
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Figure 5. m152 Prevents Maturation of Newly Synthesized Mouse
MHC Class I Molecules
B12 cells were infected with MCMV, wild-type vaccinia, or m152-
Vac. Controls were mock infected. At 4 hr postinfection, cells were
pulse labeled for 1 hr with [35S]methionine, and newly synthesized
molecules were chased for 2 hr. Cell lysates were prepared, and Kd
complexes were precipitated with a mixture of the MAbs SF1.1.1
and MA-215. The precipitates were split, and aliquots were either
digested with endo H or mock treated before separation by 13%
SDS–PAGE.
Retained MHC Class I Molecules Accumulate
in the ERGIC/cis-Golgi
In previous studies we had hypothesized that the endo
H–sensitive phenotype of MHC class Imolecules reflects
ER retention of the complexes (Del Val et al., 1992). To
identify the compartment of retention with more preci-
sion, we studied the intracellular localization of gp40
and MHC class I complexes by confocal microscopy in
MCMV-infected cells. To detect gp40, an affinity-puri-
fied rabbit antiserum raised against a synthetic peptide
derived from the luminal domain of gp40 (see Figure 1)
was used, and a monoclonal antibody to Kd served for
the detection of MHC class I complexes. B12 cells were
either mock infected (Figures 6k and 6l) or infected with
MCMV for 5 hr (Figures 6a–6j). The double staining of
gp40 and protein disulfide isomerase (PDI; Tooze et al.,
Figure 6. ERGIC/cis-Golgi Retention of MHC Class I Molecules in1989) as an ER marker in infected cells showed a spotted
MCMV-Infected Cells
distribution of the viral protein. This distribution was
Infected (a–j) and mock-infected B12 cells (k and l) were fixed withdifferent from the typical staining of the ER resident
paraformaldehyde and permeabilized with detergent prior to double
protein (Figures 6a and 6b). When the intracellular distri- labeling with rabbit anti-gp40 (a) and mouse anti-PDI antibody (b).
bution of Kd molecules was compared with the distribu- Cells were incubated with FITC-conjugated goat anti–rabbit IgG or
tion of another ER resident protein, immunoglobulin rhodamine-conjugated goat anti–mouse IgG. The subcellular distri-
bution of Kd molecules (c, e, g, and j)was compared with the distribu-heavy chain binding protein (BiP), almost no colocaliza-
tion of BiP, p58 (f), mannosidase II (i), and gp40 (h). Mock-infectedtion was seen (Figures 6c and 6d), indicating that the
cells were stained for Kd (l) and for mannosidase II (k).bulk of MHC class I molecules exit from the ER. In mock-
infected cells, no intracellular concentration of Kd mole-
cules was observed (Figure 6l). Double immunoflu-
and p58, a marker for the intermediate and early-Golgiorescence staining of Kd and the medial Golgi marker
compartment (Saraste and Svenson, 1991; Hendriks etmannosidase II (Moremen et al., 1991) (Figures 6i and
al., 1994), indicated the accumulation of Kd molecules6j) suggested a localization in the vicinity of the Golgi
in this compartment (Figures 6e and 6f). The overlappingrather than the ER, but did not reveal a perfect colocali-
zation. The comparison between the distribution of Kd staining of p58 and mannosidase II (Figures 6e and 6j)
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is in agreement with the partial colocalization typical for
markers for the intermediate compartment and for the
medial Golgi (Chavrier et al., 1990). Direct comparison
of the subcellular distribution of gp40 and Kd (Figures 6g
and 6h) showed a close similarity although no complete
identity. A complete identity was not to be expected,
because gp40 molecules mature to endo H resistance
(Figure 3c) and can be detected in a compartment with
endolysosomal characteristics (data not shown). Alto-
gether, the bulk of gp40 and Kd molecules accumulate
and colocalize in post-ER compartments, and MHC mol-
ecules colocalize with p58, a marker of the ERGIC/cis-
Golgi.
Specificity of gp40 Function for H-2 Alleles
The adenovirus E3/19K protein binds to class I alleles
from human and mouse (Signas et al., 1982). It blocks
the surface expression of all human lymphocyte antigen
(HLA) molecules and three of seven tested murine MHC
alleles. An ER retention motif in the C-terminus of the
viral protein is essential for its ability to block antigen
presentation (Jackson et al., 1990). The gp40 of MCMV
has no apparent sequence homology to E3/19K and Figure 7. m152 Acts Selectively upon Mouse MHC Class I Mole-
does not coprecipitate with MHC class I molecules. cules
However, the similar phenotype of MHC class I retention Human LC-5 cells, transfected with the mouse class I gene H-2 Kd,
were mock infected or infected with either wild-type vaccinia orcould still reflect a comparable specificity and a com-
m152-Vac. Controls were mock infected. At 4 hr postinfection, cellsmon mechanism.
were pulse labeled for 30 min with [35S]methionine. Lysates wereThe gp40 prevents the transport of all mouse MHC
either prepared directly after labeling to isolate newly synthesized
class I haplotypes (H-2d, H-2k, H-2b, and H-2q) we have MHC molecules before trimming of N-binding oligosaccharides in
tested so far (data not shown). In human cells the Golgi (first two lanes) or after a 4 hr chase period. MHC com-
transfected with the mouse class I allele H-2 Kd, the plexes were precipitated either with MAb SF1.1.1 specific for mouse
H-2 Ld (a) or with MAb W6/32 specific for human MHC class I (b).mouse MHC molecules were sensitive to the gp40 effect
(Figure 7a), whereas endogenous human class I alleles
escaped the transport block (Figure 7b). Vice versa,
presentation in the MHC class I pathway. This functionwhen a human class Iallele, HLA-B27, was stably cotran-
was noticed in the block of T cell recognition of thesfected with human b2-microglobulin into a mouse cell
antigenic nonapeptide of the MCMV immediate-earlyline, it remained refractory to the effect of gp40, whereas
protein pp89 during the early phase of viral gene expres-endogenous mouse class I alleles expressed in these
sion (Reddehase et al., 1986; Del Val et al., 1989). Herecells showed the sensitive phenotype (data not shown).
we report on the identification of the gene m152 andThus, the gp40 mediates MHC retention both in human
the characterization of its product, gp40. First, the viraland mouse cells, but acts selectively on mouse MHC
protein excludes murine MHC class I but not humanclass I alleles.
MHC molecules from further anterograde transport.
Second, the MHC complexes do not reach the plasmaThe Cytoplasmic Tail of gp40 Does Not Act
membrane, and the presentation of peptide to the CD81as a Retention Module
T cells is abrogated. Third, the intracellular expressionTo test theputative role of the 26 aminoacid cytoplasmic
of gp40 arrests MHC class I molecules in the ER–Golgidomain of gp40 as an ER retention module, we con-
intermediate compartment (Hauri and Schweizer, 1992)structed a deletion mutant lacking 25 C-terminal resi-
and cis-Golgi, defining a novel site of MHC complexdues. The deletion mutant was expressed by a vaccinia
transport arrest. Finally, the putative interaction be-recombinant and showed the expected faster mobility
tween MHC class I complexes and gp40 molecules isin gels (Figure 8a). However, this mutant did confer endo
transient, since the half-life of the molecules is differentH sensitivity to nascent Ld molecules to the same extent
and only gp40 acquires endo H resistance and leavesas the full-length gp40 construct (Figure 8b). Thus, the
the ERGIC.cytoplasmic domain containing the YXXF motif may de-
Numerous virus proteins counteract the cellular im-fine the intracellular distribution of the isolated gp40,
mune response. Several of these have been identified asbut the motif is not essential for the MHC class I–specific
mutated forms of receptors or signal molecules relevantfunction.
during inflammation (Smith, 1994). Only a few virus pro-
teins interfere with antigen recognition in the MHC classDiscussion
I pathway, and for these no cellular homolog predicted
their function. The adenovirus E3/19K protein directlyThe first set of early viral genes that are transcribed
binds to MHC class I complexes in the ER and preventsunder control of the immediate-early transcriptional acti-
vators of MCMV include a function that prevents antigen their release into the secretory pathway (Burgert and
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that mouse, but not human, class I gene products are
affected in human and mouse cells would be consistent
with a direct interaction between gp40 and mouse class
I alleles and also fits with the exquisite species specific-
ity of CMVs.
Although some aspects of the functional phenotype
induced by both virus proteins appear similar, the mo-
lecular basis of MHC retention is different. In E3/19K,
the cytoplasmic tail of the viral protein contains a dilys-
ine motif (KKXX) that provides the essential ER retention
module function. This motif is recognized by coatomer
proteins that retrieve the complex of the adenovirus
protein and MHC from the Golgi to the ER (Jackson et
al., 1990; Letourneur et al., 1994). The deletion of this
motif restores plasma membrane transport of the com-
plex. The respective protein domains do not have identi-
cal functions in E3/19K and gp40, since the mutant of
m152 that was deleted for the cytoplasmic tail still
blocked the MHC export. Notably, the cytoplasmic tail
of gp40 contains the YRLV motif, which may represent
a lysosomal targeting signal (Guarnier et al., 1993). The
motif may be responsible for the later fate of gp40. The
subcellular localization suggested that gp40 segregates
from MHC class I molecules and finally reaches the
lysosome.
The biogenesis of MHC class I molecules is guided
by transient interactions with chaperones that provide
Figure 8. The Cytoplasmic Tail of m152/gp40 Is Not Required for quality control functions in the secretory pathway (re-
MHC Class I Retention
viewed by Williams and Watts, 1995; Hammond and
L-Ld cells were infected with wild-type Vac, m152-Vac, or m152Dct- Helenius, 1995). This regulated process is not disturbedVac. At 4 hr postinfection, cells were pulsed for 1 hr and chased
by the action of gp40 because the correctly processedfor 6 hr. The m152 and m152Dct proteins were precipitated with
peptide is contained in retained MHC complexes ofthe peptide antiserum to gp40 (a). MHC class I molecules were
precipitated with antibodies to H-2 Ld (b). The precipitates were MCMV-infected cells (Del Val et al., 1992). Thus, whether
split, and one fraction was incubated with endo H before analysis gp40 meets the MHC class I already in the ER or in
by reducing 10% SDS–PAGE. the ERGIC/cis-Golgi is unknown. The segregation of the
intracellular distribution, the short half-life of gp40 com-
Kvist, 1985; Andersson et al., 1985). The HSV-1 ICP47 pared with that of retained MHC class I complexes, and
protein binds to TAP and blocks peptide transport from the acquisition of endo H resistance by gp40 molecules
the cytosol into the ER (York et al., 1994; Hill et al., 1995; excludes a permanent interaction between both pro-
Fru¨h et al., 1995). By comparison of protein properties teins. The maintenance of MHC class I retention can be
and function, it is clear that gp40 has little in common explained by binding of newly synthesized gp40 mole-
with the cytosolic HSV-1 ICP47 protein, which indirectly cules to already retained MHC class I complexes. We
prevents the formation of a stable MHC class I complex favor the alternative hypothesis, in which gp40 induces
owing to the block of peptide supply. a conformational change of the MHC class I molecule,
The E3/19K protein is a glycoprotein with two promi- which then remains stable even after dissociation of the
nent properties. The luminal portion strongly binds to viral protein. The cellular factors that may detect this
MHC complexes, and the cytoplasmic tail acts as an conformational alteration and retain MHC class I mole-
ER retention module. With the E3/19K protein gp40 cules in the ERGIC/cis-Golgi compartment will be the
shares the properties of a type I transmembrane glyco- subject of further studies.
protein and the phenotype of retaining MHC molecules The analysis of the MCMV DNA sequence (W. R., H. F.,
in thesecretory pathway. The MHC allele binding activity and B. Barell, unpublished data) confirmed the relation-
E3/19K defines the strength of the MHC retention. In ship between MCMV and HCMV. Genes located in the
contrast with E3/19K, we have so far been unable to central 100 kb of the genome are closely related be-
demonstrate a complex between gp40 and MHC class tween the viruses and more distantly related to genes
I by coimmunoprecipitation, even under mild solubiliza- from other herpesviruses. Both viruses down-regulate
tion conditions, although we could show a colocaliza- MHC class I surface expression (Del Val et al., 1992;
tion. Most likely this failure is attributable to technical Campbell et al., 1994; Beersma et al., 1993; Yamashita
conditions, e.g., gp40–MHC complexes are disrupted by et al., 1993; Warren et al., 1994). The immunoevasive
detergents. Perhaps thegp40 peptide–specificantibody functions of both MCMV and HCMV on MHC class I
detects only the noncomplexed form of the viral protein. maturation can be lifted by the activity of cytokines
Whereas the adenovirus protein preferentially binds to (Hengel et al., 1994, 1995). The MCMV gene m152 and
human MHC alleles, theMCMV protein exhibits anexclu- the HCMV genes US2, US3, and US11, which affect
MHC functions (Joneset al., 1995, 1996; Ahn et al.,1996),sive specificity for mouse MHC alleles. The observation
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In parallel, the m152 gene was cloned in the pBK-CMV plasmidare located at similar genomic positions. Recently, it
and further subcloned into the 59 SacI and 39 HindIII sites of thehas been reported that US11 affects MHC class I heavy
pGRE5-1 vector (Mader and White, 1993). This construct was co-chains by a mechanism that quickly dislocates newly
transfected with a bacterial plasmid carrying the neor resistance
synthesized class Imolecules from the ER to thecytosol, gene in L cells.
where they are degraded (Wiertz et al., 1996). The ab-
sence of stable MHC complexes in US11 transfectants RNA Analysis
NIH 3T3 cells were infected with MCMV at a multiplicity of infectionindicates that m152 and US11 operate by different
of 10. Cellular RNA was isolated at different times postinfection.mechanisms. Like gp40, the glycoprotein encoded by
Total RNA (5 mg) was electrophoresed through 0.9% formaldehyde–the HCMV immediate-early gene US3 binds and retains
agarose gels according to standard protocols. The RNA was blotted
stable and peptide-loaded MHC class I complexes in ontoa nylon membrane (Quiabrane; Quiagen, Hilten, FRG). A defined
an ER–cis-Golgi compartment (Ahn et al., 1996). US3 RNA transcript identical to the full-length coding strand of the m152
and m152 do not share sequence homologies and illus- gene was generated on the template of the m152 insert cloned into
the transcription vector pGEM-3Z (Promega, Madison, WI) by usingtrate that CMVs selected genetically different butpheno-
a riboprobe in vitro transcription system (Promega). Full-lengthtypically similar gene functions during coevolution with
cDNA from the murine b-actin gene (Stratagene), labeled withtheir hosts.
[a-32P]dCTP by using a random primer labeling system (Stratagene),
In addition to the region of the m152 gene, MCMV served as a standard for RNA levels.
contains other functions that interact with MHC I mole-
cules (Tha¨le et al., 1995; Kleijnen et al., 1996). Similarly, Cells and Transfectants
For microinjection the subclone B12 of an immortalized cell line ofin HCMV more than one gene can independently down-
BALB/c fibroblasts (Del Val et al., 1991) was grown in Dulbecco’sregulate MHC class I heavy chains (Jones et al., 1995;
modified Eagle’s medium supplemented with 10% (v/v) fetal calfAhn et al., 1996). The presence of multiple viral genes
serum. Another subclone, C12, was used for target cell preparation.that all target the MHC class I pathway of antigen pro- NIH 3T3 cells were used to analyze the transcription kinetics of
cessing and presentation appears to be unique for MCMV genes. 1T KOP B27 cells, a subclone of the Th-cell line 1T
CMVs. A hallmark of CMV genomes is the presence of 22 isolated from Swiss 3T3 cells (Arnold et al., 1984) transfected
with the human class I allele B27 were supplied by Dr. B. Arnoldtandemly arranged gene families coding for glycopro-
(Deutsches Krebsforschungszentrum, Heidelberg, FRG). LC-5-Kd isteins that usually cluster as homologous blocks of sev-
a subline transfected with the mouse class I allele Kd of the humaneral members (Chee et al., 1990; W. R., H. F., and B.
cell line LC-5 (Mellert et al., 1990), supplied by Dr. Erfle (Gesellschaft
Barell, unpublished data). The MHC-reactive genes are fu¨r Strahlenforschung, Mu¨nchen, FRG). The L-m152 transfectants
members of these families. Altogether, the presence of were propagated in the presence of 0.5 mg/ml G-418 and induced
multiple genes in different viruses that all found different with 25 nM dexamethasone for 24 hr prior to harvesting.
possibilities to regulate MHC class I complex formation
Microinjection and Immunofluorescenceand export suggests that our present understanding of
Cells were seeded on Cellocates (Eppendorf, Hamburg, FRG) andthe principles that guide the biogenesis and function of
injected with plasmid DNA and stained by antibodies specific forthe MHC class I complex is still incomplete.
the Kd allele as described previously (Tha¨le et al., 1995). Injected
cells were incubated for 24 hr at 378C and 5% CO2 and stained by
indirect immunofluorescence.Experimental Procedures
Cytolytic AssaysCloning Procedures, Virus Propagation, and Production
Infected target cells were trypsinized and labeled for 90 min withof Recombinant Vaccinia Viruses
Na251CrO4, and a standard 4 hr cytolytic assay was performed withMCMV of strain Smith (ATCC VR-194) was used as tissue culture–
103 target cells per well and graded numbers of effector cells ingrown virus. The cloned EcoRI fragments of the MCMV genome
5-fold dilution steps (Del Val et al., 1988). Data represent the meanwere provided by Dr. D. Spector (University of California, San Diego).
percentage of specific lysis from three replicate cultures.The ORF of the m152 gene was cloned after PCR amplification of
MCMV Smith DNA with oligonucleotide primers into the polylinker
of the pBK-CMV expression vector (Stratagene, La Jolla, CA) under Metabolic Labeling, Endo H Treatment,
Immunoprecipitation, and Western Blottingthe control of the HCMV immediate-early enhancer-promoter. The
primers were as follows: forward, 59-CGC GGG GGA TCC GGT CTC Cells were labeled with [35S]methionine (1200 Ci/mmol; Amersham,
Braunschweig, FRG) at a concentration of 300 mCi/ml at 378C forCCG ATC GCT AGC-39; backward, 59-CGC GGG AAG CTT GGT
CGC ACG AAC ATC ACC-39. The PCR product was cloned by using 60 min and chased in the presence of 10 mM nonlabeled methionine
as described previously (Del Val et al., 1992). Tunicamycin (5 mg/the 59 BamHI and 39 HindIII sites, resulting in a recombinant m152
gene of 1200 bp. The gene sequence was further subcloned via the ml), an inhibitor of N-linked glycosylation, was added 45 min before
and during 35S labeling. Cell lysates were precleared by adding59 BamHI and the 39 SmaI sites into the 59 BamHI and 39 EcoRV
sites of the plasmid p7.5K131. This construct was then used to anti-actin and rabbit anti–mouse immunoglobulin G (IgG). Immune
complexes were retrieved with protein A–Sepharose. Quantitativegenerate a recombinant vaccinia virus after homologous recombina-
tion with the vaccinia strain Copenhagen. The expression of the precipitations of MHC molecules were performed with ascitic fluid
containing a mixture of the monoclonal antibodies (MAbs) MA-215m152 within the vaccinia virus is driven by the vaccinia 7.5K pro-
moter. m152-Vac recombinants expressing the m152 ORF were se- (Hengel et al., 1994) and SF1.1.1 (ATCC HB159) specific for Kd, with
MAb 28-14-8S (ATCC HB27) specific for Ld, and with MAb W6/32lected by infecting HU TK2 143 cells. To generate the m152 ORF
with a deleted cytoplasmic tail, a backward primer (59-CGC GGG (ATCC HB95) specific for human class I heavy chains. As a control
for a cellular protein, the t form of 14-3-3 was precipitated by aAAG CTT TTA TCA CTT CAC CAG ATA CAT-39) was used. The
subsequent cloning strategy to generate the m152Dcyt-Vac was as rabbit antibody (Santa Cruz Biotechnology, Santa Cruz, CA). To
ensure quantitative retrieval of immune complexes, the lysates wereabove. The mutated ORF terminates after the lysine residue in posi-
tion 353. The generation of recombinant vaccinia virus expressing incubated twice with protein A–Sepharose. Endo H (Boehringer,
Mannheim, FRG) digestion was carried out as described previouslythe complete MCMV ie1 ORF coding for pp89 has been described
(Volkmer et al., 1987). The vaccinia recombinant Kd-Vac expressing (Del Val et al., 1992).
For protein blots, nylon filters (Immobilon P; Boehringer) werethe ORF of the mouse MHC class I allele Kd was prepared accord-
ingly. used. The membrane was blocked overnight at 148C by blocking
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reagent, and the binding of the primary antibody was visualized by Beersma, M.F., Bijlmakers, M.J., and Ploegh, H.L. (1993). Human
cytomegalovirus down-regulates HLA class I expression by reduc-peroxidase-conjugated sheep anti–rabbit IgG and chemilumines-
cence (Boehringer). ing the stability of class I H chains. J. Immunol. 151, 4455–4464.
Burgert, H.G., and Kvist, S. (1985). An adenovirus type 2 glycoprotein
Flow Cytometry blocks cell surface expression of human histocompatibility class I
Trypsinized L-m152 transfectants expressing the m152 gene were antigens. Cell 41, 987–997.
mock treated or induced with 25 nM dexamethasone for 24 hr. The Campbell, A.E., and Slater, J.S. (1994). Down-regulation of major
cells were washed with PBS (2% fetal calf serum, 0.3% NaN3) and histocompatibility complex class I synthesis by murine cytomegalo-
stained with MAb H100. 27.55 (anti-Kk). Bound antibodies were visu- virus early gene expression. J. Virol. 68, 1805–1811.
alized by addition of fluorescein isothiocyanate (FITC)-conjugated
Chavrier, P., Parton G.P., Hauri, H.P., Simmons, K., and Zerial, M.
goat anti-mouse antibodies (Dianova). Cells incubated with the sec-
(1990). Localization of low molecular weight GTP binding proteins
ond antibody alone served as negative controls. A total of 5 3
to exocytic and endocytic compartments. Cell 62, 317–329.
103 cells were analyzed for each fluorescent profile by FACS on a
Chee, M.S., Bankier, A.T., Beck, S., Rohni, R., Brown, C.M., Cerny,FACScan (Becton Dickinson, San Jose, CA).
R., Horsnell, T., Hutchison, C.A., III, Kouzarides, T., Martignetti, J.A.,
Preddie, E., Satchwell, S.C., Tomlinson, P., Weston, K.M., and Barell,Confocal Microscopy
B.G. (1990). Analysis of the protein-coding content of the sequencegp40 was detected by polyclonal rabbit antiserum raised against
of the human cytomegalovirus strain AD 169. Curr. Topics Microbiol.a synthetic peptide from the luminal part of the viral protein. For
Immunol. 154, 125–169.intracellular localization of gp40 and MHC class I molecules, the
Del Val, M., Volkmer, H., Rothbard, J.B., Jonjic, S., Messerle, M.,following monoclonal and polyclonal antibodies were used: MAb
Schickedanz, J., Reddehase, M.J., and Koszinowski, U.H. (1988).SF1.1.1 (anti-Kd; Pharmingen), polyclonal rabbit serum anti-GRP-
Molecular basis of cytolytic T-lymphocyte recognition of the murine78 (anti-BiP; Affinity Bioreagents, Golden, CO), MAb 1D3 (anti-PDI;
cytomegalovirus immediate-early protein pp89. J. Virol. 62, 3965–Tooze et al., 1989; provided by S. Fuller); the antibodies against p58
3972.(Saraste et al., 1991) and mannosidase II (Moremen et al., 1991)
were provided by J. Saraste and K. Moremen, respectively. Del Val, M., Mu¨nch, K., Reddehase, M.J., and Koszinowski, U.H.
Subconfluent layers of B12 cells were grown on glass coverslips (1989). Presentation of cytomegalovirus immediate-early antigen to
and infected with MCMV (multiplicity of infection of 1) for 5 hr. cytolytic T lymphocytes is selectively prevented by viral genes ex-
Noninfected cells were used as controls. Cells were rinsed with PBS pressed in the early phase. Cell 58, 305–315.
and fixed with 3% (w/v) paraformaldehyde in PBS for 20 min. After Del Val, M., Schlicht, H.-J., Ruppert, T., Reddehase, M.J., and Koszi-
blocking free aldehyde groups with 50 mM NH4Cl, 20 mM glycine nowski, U.H. (1991). Efficient processing of an antigenic sequence
in PBS, cells were permeabilized with 0.1% Triton X-100 in PBS. To for presentation by MHC class I molecules depends on its neigh-
block unspecific binding of antibodies, the coverslips were incu- boring residues in the protein. Cell 66, 1145–1153.
bated for 10 min in 0.2% (w/v) fish skin gelatine (Sigma) in PBS.
Del Val, M., Hengel, H., Ha¨cker, H., Hartlaub, U., Ruppert, T., Lucin,
Double immunofluorescence was performed by incubating cells
P., and Koszinowski, U.H. (1992). Cytomegalovirus prevents antigen
with primary antibodies in the same medium for 45 min. After exten- presentation by blocking the transport of peptide-loaded major his-
sive washing with PBS, the cells were incubated again in 0.2% tocompatibility complex class I molecules into the medial-golgi
gelatine and stained with 2% second antibodies, FITC-conjugated compartment. J. Exp. Med. 176, 729–738.
goat anti–rabbit IgG (Dianova), and rhodamine-conjugated goat
Ebeling, A., Keil, G.M., Knust, E., and Koszinowski, U.H. (1983).anti–mouse IgG (Dianova) for 45 min. After washing with PBS, the
Molecular cloning and physical mapping of murine cytomegalovirusglass coverslips were mounted on glass slides with Histogel (Ca-
DNA. J. Virol. 47, 421–433.mon). The mounted cells were analyzed with a laser scanning confo-
Fru¨h, K., Ahn, K., Djaballah, H., Sempe´, P., van Endert, P.M., Tampe´,cal microscope (Leitz DM IRB; scanner, Leica TCS 4D).
R., Peterson, P.A., and Yang, Y. (1995). A viral inhibitor of peptide
transporters for antigen presentation. Nature 375, 415–418.Acknowledgments
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